Estrogen, GLP-1s, and DTE 

During this exclusive session, Angela DeRosa, DO, MBA, CPE, Belmar Medical Director, and Scott Brunner, CEO, Alliance for Pharmacy Compounding (APC) break down the latest regulatory developments affecting compounding. 

In this webinar, you will learn:  

• Current legislative actions impacting 503A and 503B pharmacies 
• How these changes could influence provider prescribing options and patient access 
• How to make your voice heard through APC’s advocacy initiatives 
• Belmar’s ongoing commitment to protecting personalized medicine for every patient in all 50 states 

Watch on-demand today. 

This webinar is intended for providers. If you are a provider and would like to watch the webinar, please fill out the form below.